• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体-毒素杂交物:其应用的临床综述

Antibody-toxin hybrids: a clinical review of their use.

作者信息

Frankel A E

出版信息

J Biol Response Mod. 1985 Oct;4(5):437-46.

PMID:3935755
Abstract

Immunotoxins are protein molecules composed of monoclonal antibodies linked covalently to either peptide toxins or polypeptides related to toxins. These molecules can be used in the therapy of a number of malignant diseases including lymphoma, leukemia, and solid tumors. They can be used to prevent graft-versus-host disease or rejection in transplanted organs, such as bone marrow and pancreas. The design and development of these molecules, as well as a clinical development plan, will be discussed.

摘要

免疫毒素是由单克隆抗体与肽毒素或与毒素相关的多肽共价连接而成的蛋白质分子。这些分子可用于治疗多种恶性疾病,包括淋巴瘤、白血病和实体瘤。它们可用于预防移植器官(如骨髓和胰腺)中的移植物抗宿主病或排斥反应。将讨论这些分子的设计与开发以及临床开发计划。

相似文献

1
Antibody-toxin hybrids: a clinical review of their use.抗体-毒素杂交物:其应用的临床综述
J Biol Response Mod. 1985 Oct;4(5):437-46.
2
Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.在患有致命遗传性疾病(不包括严重联合免疫缺陷)的儿童中,采用来自基因上HLA不匹配供体的骨髓移植:使用两种单克隆抗体预防移植物排斥反应。
Pediatrics. 1996 Sep;98(3 Pt 1):420-8.
3
XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.XomaZyme-CD5免疫毒素联合部分T细胞清除用于预防匹配无关供者骨髓移植后的移植物排斥反应和移植物抗宿主病。
Bone Marrow Transplant. 1994 May;13(5):571-5.
4
Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?异基因骨髓细胞移植后进行主动免疫接种:癌症免疫治疗的一种新选择?
Arch Immunol Ther Exp (Warsz). 2002;50(3):197-224.
5
Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.异基因骨髓移植中的移植物抗宿主病:单克隆抗体在预防和治疗中的作用
Br J Biomed Sci. 2000;57(2):163-9.
6
Antibody-based therapeutics in oncology.肿瘤学中基于抗体的治疗方法。
Expert Rev Anticancer Ther. 2003 Feb;3(1):107-21. doi: 10.1586/14737140.3.1.107.
7
[Use of antibodies or their fragments for the treatment of tumors].[抗体或其片段在肿瘤治疗中的应用]
Bull Cancer. 1998 Nov;85(11):951-9.
8
A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.展望未来:预测、预防与治疗,包括胰岛移植和干细胞治疗。
Pediatr Clin North Am. 2005 Dec;52(6):1779-804. doi: 10.1016/j.pcl.2005.07.002.
9
Anticancer antibodies.抗癌抗体
Am J Clin Pathol. 2003 Apr;119(4):472-85. doi: 10.1309/Y6LP-C0LR-726L-9DX9.
10
Prospects for immunotoxin therapy in cancer.癌症免疫毒素疗法的前景。
Annu Rev Med. 1986;37:125-42. doi: 10.1146/annurev.me.37.020186.001013.

引用本文的文献

1
Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft model.HuCC49DeltaCH2-beta-半乳糖苷酶在结直肠癌异种移植模型中的生物分布。
Int J Pharm. 2010 Feb 15;386(1-2):208-15. doi: 10.1016/j.ijpharm.2009.11.020. Epub 2009 Nov 26.
2
Monoclonal antibodies and immobilized antibodies. Patents and literature.单克隆抗体与固定化抗体。专利与文献。
Appl Biochem Biotechnol. 1987 Jun;15(1):53-80. doi: 10.1007/BF02798506.
3
A cytotoxic agent can be generated selectively at cancer sites.一种细胞毒性剂可以在癌症部位被选择性地产生。
Br J Cancer. 1988 Dec;58(6):700-3. doi: 10.1038/bjc.1988.293.
4
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys.一种用于治疗T急性淋巴细胞白血病性脑膜炎的免疫毒素:恒河猴研究
Cancer Immunol Immunother. 1989;28(1):59-66. doi: 10.1007/BF00205802.